IRONWOOD PHARMACEUTICALS INC. overview

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Cyclerion Therapeutics, Inc. (Cyclerion) has entered into an agreement for a private placement of up to $175 million. The offering includes commitments from existing Ironwood shareholders, new investors, and certain members of future Cyclerion management. Final proceeds from this offering are expected to support Cyclerion’s sGC stimulator portfolio for at least two years, including four clinical data readouts expected in the...

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 8 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 11:00 a.m. Eastern Time at the Lotte New York Palace in New York. A live webcast of Ironwood’s presentation will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com . To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to...

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a commercial biotechnology company, today provided an update on its fourth quarter and full year 2018 results and recent business activities. “The fourth quarter capped off a year of solid LINZESS volume growth and progress with our pipeline of seven differentiated product candidates,” said Peter Hecht, chief executive officer (CEO) of Ironwood. “2018 was a momentous year for Ironwood, as we made the decision to separate into two independent,...

Sarissa Capital Issues Statement On Ironwood Pharmaceuticals PR Newswire GREENWICH, Conn., May 31, 2018 GREENWICH, Conn. , May 31, 2018 /PRNewswire/ -- Sarissa Capital Management LP today made the following statement regarding Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD). We believe the plan to separate Ironwood's R&D programs from its commercial business is a good first step toward creating shareholder value at Ironwood while preserving strategic optionality. In meeting with Ironwood we...

NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 4:30 PM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/24469 . Replay Information The replay will be available online at https://www.investornetwork.com/company/24469 . About Investor Network Investor Network (IN) is a new financial content community,...

NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) will be discussing their earnings results in their Q1 Earnings Call to be held May 8, 2017 at 8:30 AM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/24469 . Replay Information The replay will be available online at https://www.investornetwork.com/company/24469 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of...